Fig. 5From: Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry studyResponder analysis RULM. Alluvial diagram to demonstrate changes in RULM over time for each cohort. Colors of columns indicate response groups according to changes in RULM score per time-period (baseline-m14, m14–m26, m26–m38). Lines between columns indicate the progression between time-periodsBack to article page